NS · Pharmaceuticals

AstraZeneca Pharma India Ltd (ASTRAZEN)

Pharmaceuticals & Biotechnology

AstraZeneca Pharma India Ltd (ASTRAZEN) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $212.03B, P/E ratio is 113.06, net margin is 9.0%, dividend yield is 0.38%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ASTRAZEN

Market cap

$212.03B

P/E ratio

113.06

Net margin

9.0%

Dividend yield

0.38%

AstraZeneca Pharma India Ltd (ASTRAZEN) — FAQ

What is AstraZeneca Pharma India Ltd's market cap?

AstraZeneca Pharma India Ltd (ASTRAZEN) has a reported market cap of $212.03B (data as of 2026-07-10).

What is ASTRAZEN's P/E ratio?

The price-to-earnings (P/E) ratio for AstraZeneca Pharma India Ltd (ASTRAZEN) is 113.06 (data as of 2026-07-10).

Does AstraZeneca Pharma India Ltd pay a dividend?

AstraZeneca Pharma India Ltd (ASTRAZEN) shows a reported dividend yield of 0.38%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is AstraZeneca Pharma India Ltd in?

AstraZeneca Pharma India Ltd (ASTRAZEN) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is ASTRAZEN listed on?

ASTRAZEN is listed on NS.

What is AstraZeneca Pharma India Ltd's net margin?

AstraZeneca Pharma India Ltd (ASTRAZEN) reports a net margin of 9.0% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)